| Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research HW Chan, S Chow, X Zhang, Y Zhao, HHY Tong, SF Chow AAPS PharmSciTech 24 (4), 98, 2023 | 31 | 2023 |
| Role of particle size in translational research of nanomedicines for successful drug delivery: Discrepancies and inadequacies HW Chan, S Chow, X Zhang, PCL Kwok, SF Chow Journal of Pharmaceutical Sciences, 2023 | 11 | 2023 |
| Synthesis of the first remdesivir cocrystal: design, characterization, and therapeutic potential for pulmonary delivery SN Wong, KH Low, YL Poon, X Zhang, HW Chan, SF Chow International Journal of Pharmaceutics 640, 122983, 2023 | 7 | 2023 |
| Development of Favipiravir Dry Powders for Intranasal Delivery: An Integrated Cocrystal and Particle Engineering Approach via Spray Freeze Drying SN Wong, S Li, KH Low, HW Chan, X Zhang, S Chow, B Hui, PCY Chow, ... International Journal of Pharmaceutics, 123896, 2024 | 5 | 2024 |
| Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation HW Chan, X Zhang, S Chow, DCL Lam, SF Chow International Journal of Pharmaceutics, 123877, 2024 | 3 | 2024 |
| Rational design and fabrication of paclitaxel-curcumin nanosuspensions as a potential inhaled therapy for non-small cell lung cancer HW CHAN, X Zhang, SF Chow CRS 2022 Annual Meeting, 2022 | | 2022 |
